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Abstract  
Introduction: Currently, the most available treatment for acute ischemic stroke (AIS) is thrombolytic therapy 
with recombinant tissue plasminogen activator (r-TPA). A challenge in r-TPA therapy is the prediction of 
recovery in each case.  
Objective: The aim was to find a possible relationship between the cerebral oximetry indexes and the clinical 
outcome of r-TPA therapy to assess the cerebral oximetry as a non-invasive monitoring agent for therapy. 
Methods: The inclusion criteria were all patients with AIS who received r-TPA. The neurologic status was 
evaluated based on the national institutes of health stroke scale (NIHSS) score at arrival, and after a period of 
24 hours. In addition, the levels of brain oxygenation in both hemispheres were measured before and 
continuously over the first 24 hours after r-TPA injection, using an oximetric sensor in the frontal lobes. The 
clinical success was defined as a 4-point improvement from the baseline NIHSS. 
Results: Total 44 patients with the mean age of 58.2 ± 2.18 years were enrolled, of whom 68.18% were male. 
Twenty-eight patients remained clinically unimproved and 16 patients were improved. A significant difference 
was found in the mean surface area under the brain oximetric curve in the 24 hour, in the affected hemisphere 
in the improved group, compared to the unimproved group (P = 0.007). There was a significant difference 
between the mean increase in brain oxygenation within 24 hours in the improved and unimproved groups (P 
= 0.002). 
Conclusion: It is likely that, The cerebral oximetry could contribute to predict the likelihood of r-TPA 
prognosis in patients with AIS. 
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INTRODUCTION
Cerebrovascular disease is the second cause of 
death and the sixth cause of severe morbidity 
worldwide, which will rise to 4th place by 2020 (1). 
About 85% of cerebrovascular disease is acute 
infarct, classifying to ischemic (85%) and 
hemorrhagic (15%) (2). Regarding the increasing 
rate of stroke-related deaths and disability-
adjusted life years (DALYs), compared to all 
diseases, the early diagnosis and consequent 
appropriate treatment are of paramount of 
importance. Currently, the treatment of acute 
ischemic stroke (AIS) is based on the early 
reperfusion and secondary stroke prevention (3–
6). The most available treatment in the acute phase 
after3-4.5 hours of the ictus is thrombolytic 
therapy with recombinant tissue plasminogen 
activator (r-TPA), which seems to contribute to 
30% improvement over a three-month period (3–
11). A challenge in reperfusion therapy by r-TPA is 
the prediction of recovery for each patient. General 
prognostic factors are patients’ age, female gender, 
prestrike functional state, infarct volume, diabetes 
mellitus, heart failure and fever. In recent years, 
new prognostic factors like hemostasis 
biomarkers, serum hepatocytes growth factor 
(HGF) and lesional and contra-lesional brain 
activity, measured by conventional 
electroencephalography (EEG), have been of 
interest, which needed more comprehensive 
studies (12–16). So far, no distinct measurement 
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has been performed on patients who received r-
TPA in order to predict the prognosis. Near-
infrared spectroscopy (NIRS) -guided cerebral 
oximetry, which is associated with regional 
cerebral perfusion and/or oxygenation, provides 
non-invasive access to the brain to determine 
regional cerebral oxygen saturation (rSO2). Despite 
the use of NIRS-guided oximetry in brain trauma, 
cardiac surgery and neonatal intensive care unit 
(ICU), this method has not gained any attention in 
stroke (17–23). In 2015, Hametneret al. 
recommended cerebral NIRS index rSO2 as a 
predictive factor of death in patients with AIS who 
had been under endovascular intervention (20). 
Herein, we aimed to show the relationship between 
the cerebral oximetry measure and the clinical 
outcome of patients with AIS who had been under 
intravenous r-TPA in ICU to determine the NIRS 
guided cerebral oximetry as a tool and non-
invasive factor to monitor cerebral function in r-
TPA therapy.  
METHODS 
Study design 
This correlation study was conducted during 2017 
and 2018 in the Poursina hospital, Rasht, Iran. The 
study was approved by the ethics committee of 
Guillan University of Medical Sciences (Code: 
IR.GUMS.REC.1396.351). In addition, written 
informed consents were obtained from all patients 
prior to their participation in this study. 
Study population 
As this is the first study, focusing on cerebral 
oximetry as a prognostic factor in patients with AIS, 
who underwent acute reperfusion by r-TPA, and 
more importantly, due to the limit in the sample 
size, we had to include all the patients with AIS, 
referred to our center by the neurologist who 
fulfilled the criteria of r-TPA (24). Early infarct 
signs > 1/3 territory of middle cerebral artery was 
considered as exclusion criteria. 
Intervention and data gathering 
Following the hospitalization of patient in the ICU, 
r-TPA (0.9 mg/ kg up to a maximum dosage of 90 
mg) was injected. The severity of the clinical 
symptoms was evaluated based on the national 
institutes of health stroke scale (NIHSS) score at 
arrival, after a period of 24 hours (every 15 
minutes) and a week. The clinical success was 
defined as a 4- point improvement from the 
baseline NIHSS score (25). 
Furthermore, the levels of oxygen of the brain 
tissue in both hemispheres were measured before 
r-TPA injection, and continuously over the first 24 
hours after reperfusion therapy, by a non-invasive 
oximetric sensor in the frontal, left and right lobes. 
The device used in this process was cerebral and 
somatic oximetry, which is manufactured by the 
Nonin Medical Company (USA). 
Eventually, the data collection was performed by a 
checklist, prepared by referring to the patients’ 
chart, including the patients’ characteristics such 
as age, sex, height, weight, past medical history, 
habitual patient file, blood pressure, SPO2, brain 
rSO2 and complication of the r-TPA. 
Statistical analysis 
After data collection, the statistical analysis was 
performed, using SPSS software version 22.0. 
Normal data distribution was performed by the 
Kolmogorov-Smirnov test. For comparison 
between two groups, independent t-test and 
Mann–Whitney test were applied. The odds ratio 
was estimated by logistic regression test. The mean 
area under the curve (AUC) of brain oximetric was 
measured in both clinically improved and 
unimproved groups. 
RESULTS 
Totally, 44 patients with the mean age of 58.2±2.18 
years were enrolled, of whom 68.18% were males. 
The summary of patients’ characteristics is 
presented in table 1. Among them, 28 patients were 
categorized into the unimproved group and 16 
patients in the improved group. Among the 
unimproved group, three patients died after 24 
hours. There was not a statistical difference 
Table 1: Patients’ characteristics at arrival 
Variable 
Improved group (n=16) Unimproved group (n=28) 
P value 
N (%) 
Age (year)    
<65 8 (50.0) 15 (53.6) 0.82 
≥65 8 (50.0) 13 (46.4) 0.82 
Sex      
Female 4 (25.0) 10 (35.7) 0.52 
Male 12 (75.0) 18 (64.3) 0.52 
Involved hemisphere    
Right 7 (43.8) 6 (21.4) 0.118 
Left 9 (56.2) 22 (78.6) 0.118 
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between age (p=0.82) and sex (p=0.52) in 
unimproved and improved groups. In addition, no 
statistical difference was found between primary 
NIHSS, in two groups (14.75±2.8 and 13.7±2.8 in 
improved and in unimproved group, respectively) 
(p=0.085).  
Additionally, the mean rSO2 in both affected and 
unaffected hemispheres was measured in both 
groups. Our findings revealed a statistical 
difference in brain oxygenation of the affected 
hemisphere, in both improved (p=0.002) and 
unimproved (p=0.0001) groups over different 
 
Figure 1: The mean area under the curve of brain oximetric in the affected hemisphere in improved and unimproved groups over 
different periods within 24 hours 
 
 
Figure 2: The mean area under the curve of brain oximetric, in the unaffected hemisphere in improved and unimproved groups over 
different periods within 24 hours 
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periods within 24 hours. By using two independent 
sample t-test, a statistical significant difference in 
the affected hemisphere oxygenation was observed 
between improved and unimproved groups, at 
different times before treatment, such as 15, 45, 60 
minutes (p=0.011, 0.026, 0.041 and 0.014, 
respectively) and 12, 13, 14, 15, 16, 24 hours 
(p=0.001, 0.0001, 0.0001, 0.0001, 0.0001 and 
0.0001, respectively). In addition, there was a 
statistical difference in brain oxygenation of the 
unaffected hemisphere in both improved 
(p=0.001) and unimproved (p=0.003) groups over 
different periods within 24 hours. By using two 
independent sample t-test, a statistical difference 
in the unaffected hemisphere oxygenation was 
observed between improved and unimproved 
groups at different times such as 30, 45, 60, 75 
minutes (p=0.008, 0.044, 0.002 and 0.001, 
respectively) and 8, 11, 12, 13, 14, 15, 16, 24 hours 
(p= 0.019, 0.001, 0.001, 0.0001, 0.0001 and 0.0001, 
respectively). The summary is presented in figures 
1 and 2. 
The mean AUC of brain oximetric in the affected 
hemisphere was also assessed, showing a 
considerable difference between improved and 
unimproved groups (73.02± 3.28 vs. 70.41 ± 2.70; 
p=0.007). Furthermore, there was not a statistical 
difference of the mean AUC of the unaffected 
hemisphere oximetric between improved and 
unimproved groups (73.72± 2.63 vs. 72.6 ± 4.49; 
p=0.272).  
Moreover, a statistical significant difference was 
observed between the mean increase in brain 
oxygenation of the both affected and unaffected 
hemispheres between the improved and 
unimproved groups within 24 hours (p=0.0001). In 
addition, a considerable statistical difference was 
observed between the mean increase in brain 
oxygenation between affected and unaffected 
hemispheres (5.02± 2.22 vs. -0.88 ± 11.1; p=0.002).  
Eventually, using Binary Logistic Regression, the 
intervening factors of neurological improvement, 
consisting of the mean increase of brain 
oxygenation, age and sex were evaluated, 
suggesting that the mean increase of brain 
oxygenation is the only modifying factor, which 
potentially can contribute to a clinical 
improvement. Such as increasing the brain 
oxygenation of the affected hemisphere leads to 
34% clinical improvement (Table 2).  
DISCUSSION 
In this study, we aimed to focus on the cerebral 
perfusion change after 24 hours following r-TPA, as 
a reperfusion therapy in patients with AIS, who 
hospitalized in the ICU with continuous NIRS-
guided cerebral oximetry. 
Given the increasing frequency of stroke in recent 
years, the early treatment of acute ischemic 
cerebral infarct is of paramount of importance. The 
most available treatment in the acute phase of AIS 
is r-TPA therapy (3–11). A considerable challenge 
in acute reperfusion therapy is to determine which 
patient benefit more from the treatment. 
NIRS-guided cerebral oximetry, associated with 
regional cerebral perfusion and/or oxygenation, 
provides non-invasive access to the brain to 
determine rSO2 (17–22). Since1997, various 
studies have been done to yield the effectiveness of 
regional oximetry in different clinical settings as 
the study of Shuler et al. who showed tissue 
oxygenation increase measured by infrared 
spectroscopy while tibial fracture (23–33). In the 
study of Orihashi et al. on 59 patients with aortic 
surgery, after cerebral perfusion monitoring in 
post-surgery, they showed that a drop in rSO2 over 
cardiac surgery was highly related to neurologic 
deficit (24). Interestingly, Robert et al. evaluated 
six patients with diabetic ketoacidosis after 24 
hours with NIRS-guided cerebral oximetry, serial 
brain CT, trans-cranial Doppler (TCD), and serial 
measurement of S100; their findings revealed a 
normal to increased cerebral blood flow, elevated 
regional cerebral oxygenation and impaired auto-
regulation in the patients without a significant 
change in S100. Due to availability of cerebral 
oximetry, they recommended cerebral oximetry as 
a monitoring factor in clinically ill patients with 
diabetic ketoacidosis (25). In the field of pediatric 
emergency, Fortune et al. worked on the patients 
with acute abdominal pain. They showed by using 
NIRS-guided oximetry, the cerebrosplanchnic 
Table 2: The intervening factor of clinical improvement 
Variables in the Equation B SE Wald Df Sig. Exp(B) 
95.0% CI for 
EXP(B) 
Lower Upper 
Affected hemisphere oxygenation increase 0.298 0.101 8.813 1 0.003 1.348 1.107 1.641 
Sex -0.315 1.086 0.084 1 0.772 0.730 0.087 6.136 
Age 0.771 1.015 0.577 1 0.448 2.162 0.295 15.824 
Constant -1.669 0.804 4.311 1 0.038 0.188 - - 
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oxygenation ratio could be assessed, which could 
help to detect early splanchnic ischemia in 
neonates (26).  
Moreover, some studies have been done on the 
influence of NIRS-guided regional oximetry on the 
management of patients with trauma, which 
highlighted the importance of regional oximetry to 
screen neurologic deficit due to hypoxia or to 
detect compartment syndrome. Furthermore, few 
studies suggested the cerebral oximetry as a 
predictive factor of transfusion in hemorrhagic 
shock (27–30). 
In the field of Neuroradiology, NIRS-guided 
cerebral oximetry has been taken into 
consideration. In a case report, Luer et al. evaluated 
a patient with subarachnoid hemorrhage due to 
ruptured middle cerebral artery aneurysm, and 
showed NIRS-guided cerebral oximetry was more 
sensitive than TCD to screen vasospasm (31). 
Additionally, there are reports of NIRS-guided 
cerebral in neurovascular interventions as in 
balloon test occlusion, aneurysm embolization or 
dural arteriovenous fistula embolization (31–34). 
Recently, much attention has been paid to cerebral 
oximetry over reperfusion therapy during acute 
ischemic events. In a case series, Hiramatsu 
demonstrated that despite complete recanalization 
in all three patients, the NIRS revealed a 
considerable rSO2 response in large vessel 
involvement, compared to no change of rSO2 in 
patients with distal middle cerebral artery 
occlusion (35). Similarly, in the study of Hametner 
et al. on 43 patients with acute stroke who 
underwent thrombectomy with continuous 
cerebral oximetry, they revealed that before 
recanalization, 10 distinct rSO2 decreases occurred 
in 11 patients. During recanalization, two patterns 
of rSO2 increase occurred in the affected 
hemisphere. Lower AUC, 10% below baseline was 
associated with better reperfusion status. 
Eventually, at the end of the treatment, lower 
interhemispheric rSO2 difference predicted death 
within 90 days and higher rSO2 variability 
predicted poor outcome (20). 
Our findings showed that there was a statistical 
difference of the mean rSO2 in both affected and 
unaffected hemispheres, in both improved and 
unimproved groups over different periods within 
24 hours (p=0.002 and 0.0001, respectively).  The 
changes in the first hours could be explained by the 
onset, peak and half-life of the r-TPA, and the 
change in the last hours could be explained by the 
fact that the cerebral rSO2 is closely related to the 
systemic changes as cardiac output, pulse rate and 
vascular resistance, which themselves are 
influenced by the intracranial pressure, 
autoregulation and cerebrovascular response to 
CO2, which are all impaired in AIS (36). 
Furthermore, we showed a statistical significant 
difference between the mean increase in brain 
oxygenation of the both affected and unaffected 
hemispheres between the improved and 
unimproved groups within 24 hours (p=0.001), 
which was more in the affected hemisphere. We 
concluded that a ≥10% increase of brain 
oxygenation, compared to the baseline was related 
to a clinical improvement. In contrast, in the 
unimproved group, despite the primary rise of 
rSO2, the eventual brain oxygenation decreased 
after 24 h, in comparison to the baseline. Among 
the three patients who died after 24 hours, we 
found the baseline brain oxygen saturation was ≤ 
50 and during the r-TPA therapy, the brain 
oxygenation level had been decreasing to more 
than 20%. 
 It should be noted that the mean regional 
oxygenation of the affected hemisphere increased 
both in the improved and unimproved groups, 
explaining the impairment of autoregulation of the 
affected hemisphere, which subsequently results in 
an increased blood flow due to sympathetic system 
malfunction and shift of blood flow from the 
unaffected site toward the affected site. Besides, it 
mentions the risk of hyperemia in the affected 
hemisphere (37).  
Furthermore, we showed a considerable difference 
of the mean AUC of the brain oximetric in the 
affected hemisphere (p=0.007), in comparison to 
the unaffected hemisphere, which did not show a 
statistical difference between improved and 
unimproved groups (p=0.272). This highlights the 
effect of thrombolytic therapy to preserve the 
penumbra area, which is susceptible to infarct and 
irreversible damage.  
In addition, our data showed no statistical 
correlation between sex and the mean increase of 
brain oxygenation and the mean AUC oximetric, in 
both improved and unimproved groups, which is 
similar to the findings of Boehme et al. who 
evaluated 4925 patients with AIS over 2001-2014. 
They showed that race and gender were not related 
to short term outcome (38). 
Eventually, we showed no statistical correlation 
between age and the mean increase of brain 
oxygenation, and the mean AUC of the oximetric in 
both improved and unimproved groups, which is 
not consistent with other studies, such as the study 
of Berrouschotet al. on the outcome and severe 
hemorrhagic complications of intravenous r-TPA, 
showing worse outcome in patients older than 80 
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years. However, the risk of hemorrhagic 
transformation was not related to age (39). 
Limitation 
The main limitation of our study was the small 
sample size.  As one of the most noticeable 
concerns in AIS is the golden time when the patient 
is referred to the hospital, we also encountered a 
gap between the onset of the symptoms and the 
hospitalization, which consequently resulted in the 
use of small size of participants. 
CONCLUSIONS 
In summary, we could apply NIRS-guided cerebral 
oximetry to monitor the cerebral oxygenation over 
acute reperfusion therapy, which could be used as 
a predictive factor. As we showed ≥ 10% increase 
in the brain oxygenation of the affected hemisphere 
increases the likelihood of clinical improvement up 
to 34%, over 2h hours of hospitalization. In 
contrast, a low level of brain oxygenation at the 
baseline is highly related to poor outcome, which 
led to death in our three patients. However, the 
increase of brain oxygenation has the risk of 
hyperemia and the consequent hyperperfusion 
syndrome. As a result, we suggest more 
investigations in this field with the simultaneous 
use of TCD of the affected hemisphere to monitor 
the autoregulation of the affected hemisphere. In 
addition, due to limitation of NIRS-guided cerebral 
oximetry in small vessel occlusion monitoring, the 
infarcted region in future researches should be 
evaluated. 
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